The success of TAVR has also sparked research into transcatheter solutions for other valve diseases, including mitral and ...

This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.

In a powerful story where medical science meets humanity, Marengo CIMS Hospital has created history by successfully ...

Kenneth Liao, MD, PhD, completed his 900th robotic heart surgery in December.  Robotic procedures that Dr. Liao and his team ...

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

Edwards Lifesciences stock is supported by its growth outlook and the impact of clinical advances. See why investors should ...

Judy Ortt at 80 ran out of options to treat her heart disease, until a new, minimally invasive technology became available at ...

Irvine, California Friday, December 26, 2025, 11:00 Hrs [IST] ...

Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve replacement system.

Louisville, Ky.-based Norton Heart & Vascular Institute performed Kentucky’s first transcatheter tricuspid valve replacement using the Evoque system. The catheter-based procedure, developed by Edwards ...

ALBANY, N.Y (WNYT) — Albany Medical Center has performed the region’s first minimally invasive tricuspid valve replacement, benefiting patients with inoperable leaky heart valves. Doctors used the ...